Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter Double-blind Randomized Parallel Comparative Study of Efficacy and Safety of BCD-066 (CJSC BIOCAD, Russia) and Aranesp (Amgen Europe B.V., Netherlands) in Treatment of Anemia in Chronic Kidney Disease Patients on Dialysis

NCT02506868 is registered in ClinicalTrials.gov with Biocad as lead sponsor.

NCT NCT02506868
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02506868 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter Double-blind Randomized Parallel Comparative Study of Efficacy and Safety of BCD-066 (CJSC BIOCAD, Russia) and Aranesp (Amgen Europe B.V., Netherlands) in Treatment of Anemia in Chronic Kidney Disease Patients on Dialysis
Lead sponsor
Biocad
Phase
Phase 3
Overall status
Completed
Start date
August 8, 2015
Completion date
December 21, 2017
Enrollment
196 (actual)
Sites
30

Conditions

As the registry lists them; a condition with its own page is linked.

anemia, chronic kidney disease, end stage renal failure on dialysis